Facts & figures

As of:  January, 2016
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992
2) primarily from own ressources, since 2001

3) primarily from own ressources

4) since 2009
5)since 2006

Research Institutions of Campus Berlin-Buch
Employees (total)

of these:    
Max Delbrück Center for Molecular Medicine (MDC): 1,624  
Leibniz Institute of Molecular Pharmacology (FMP): 275  
Klinische Forschung Charité Campus Buch: 192  
Budget and third-party grants (total)1 EUR 144 million  
Max Delbrück Center for Molecular Medicine (MDC): EUR 104 million  
Leibniz Institute of Molecular Pharmacology (FMP): EUR 24 million  
Klinische Forschung Charité Campus Buch: EUR 16 million  
BiotechPark Berlin-Buch    
Number of companies: 63  
Employees: 800  
Annual revenue:
Percentage of third-party grants: 3,1%

EUR 160 million
Hospitals & Patient-Care Institutions    
Employees (total):
of these:
HELIOS Klinikum Berlin-Buch: 2,550  
Evangelische Lungenklinik: 314  
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik):
Patient-care institutions: 450  
Number of patient beds: 1232  
Patients per year (inpatient and outpatient): 199,400  
Total investment volume
of these:
EUR 1.219 billion  
Infrastructure Campus Berlin-Buch1 EUR 502 million  
HELIOS Klinikum Berlin-Buch² EUR 304 million  
Evangelische Lungenklinik3 EUR 49 million  
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1
EUR 38 million
LudwigPark3 EUR 45 million  
Allées des Châteaux3 EUR 23 million  
Widerker Vermögensverwaltung (Schlosspark-Passage)3
EUR 28 million
Housing construction associations (HOWOGE3,4, EWG3,5, Hau+S3,5)
EUR 120 million
Ludwig Hoffmann Quartier EUR 110 million  

News Buch Berlin

An in-depth atlas of the heart

Researchers from three continents have produced a first extensive draft of a cell atlas of the human heart to understand how this vital organ functions and to shed light on what goes wrong in cardiova...

more ...

DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms

DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno-oncology company built on world-leading glycobiology expertise, today announced an expa...

more ...

Towards a cell-based interceptive medicine in Europe

Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime St...

more ...

Events Buch Berlin

24.10.2020, 09:00
Auf zum „WanderHerbst“ mit der Niederbarnimer Eisenbahn: Romantischer Liepnitzsee

28.10.2020, 09:00
DIGITALE LIFE SCIENCES – Workshops zu den Grundlagen der Bioinformatik und zum Labor 4.0

Neuer Kurs für Technische Angestellten und Laboranten in den Life Sciences: Überblick über aktuelle Themen zur Bioinformatik, Digitalisierung und Automatisierung

more ...

29.10.2020, 15:00
„Das Bunte Café“ im Bucher Bürgerhaus

This website is supported by: